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Abstract 
Cardiovascular diseases (CVD) continue to be the leading cause of morbidity and mortality in most 
developed countries [1]. Several epidemiological studies have linked flavonols with decreased risk of 
stroke [2] and CVD [3], whilst human intervention studies have shown improvements in several 
biomarkers of CVD risk after flavonol consumption [4]. However, some heterogeneity in the individual 
physiological responses to the consumption of these compounds has been identified. For example, age 
and stage of hypertension seem to be important factors influencing the blood pressure lowering effect 
of quercetin [5, 6]. This meta-analysis aims to analyse the effect of flavanol intake on blood lipids, one 
of the major biomarkers of CVD risk, and factors affecting the inter-individual variability. 
A systematic search was conducted in PubMed, Web of Science, Scopus and trial registry platforms. 
Only human randomized controlled trials with measured cardiometabolic outcomes were selected for 
data extraction of the measured outcomes, individual factors of the participants, characteristics of the 
study, and study quality. From 671 screened references, 19 studies were selected for data extraction 
and 16 studies were used for meta-analysis on total cholesterol, LDL, HDL and triacylglycerides (TAG). 
Inter-individual variability was assessed by subgroup analysis on BMI, age, sex, country and health 
status. Estimated intervention/control standardized mean differences suggested that consumption of 
flavonols was associated with significant reductions in total cholesterol (-0.180 mmol/L, 95% CI -0.307, 
-0.053), LDL (-0.219 mmol/L, 95% CI -0.350, -0.088) and TAG (-0.280 mmol/L, 95% CI -0.408, -0.151) 
and a significant increase in HDL (0.235 mmol/L, 95% CI 0.104, 0.365). Subgroup analysis showed a 
more pronounced effect in Asian countries and in participants with normal baseline lipid levels, 
compared to borderline and high baseline values. Results suggest that ethnicity and health status may 
influence the effect of flavonol intake on blood lipid levels. 
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